OpenAI has introduced a new artificial intelligence model called GPT-Rosalind to help scientists accelerate life science research, including research in biology and drug discovery.
According to a post on the OpenAI blog on Thursday (16/4), the new artificial intelligence (AI) model is named after Rosalind Franklin, whose research helped uncover the structure of DNA and became the foundation of modern molecular biology.
Scientific research relies heavily on data. GPT-Rosalind is designed to help sort through data and reduce the time required to develop, approve, and market new drugs.
OpenAI said in a blog post that it takes 10 to 15 years to develop and obtain approval for a new drug in the United States.
According to a C-net release GPT-Rosalind is designed to improve research target selection and create stronger hypotheses for higher-quality experiments.
This model has been tested on topics such as organic chemistry, proteins, and genetics. Researchers can use it to find relevant scientific literature for their work or design experiments.
